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Upon activation, ERKs translocate from the cytoplasm to the
nucleus.This process is required for the inductionofmany cellular
responses, yet the molecular mechanisms that regulate ERK
nuclear translocation are not fully understood. We have used a
mouse embryo fibroblast ERK1-knock-out cell line expressing
green fluorescent protein (GFP)-tagged ERK1 to probe the spatio-
temporal regulation of ERK1. Real time fluorescence microscopy
and fluorescence correlation spectroscopy revealed that ERK1
nuclear accumulation increased upon serum stimulation, but the
mobility of the protein in the nucleus and cytoplasm remained
unchanged. Dimerization of ERK has been proposed as a require-
ment for nuclear translocation. However, ERK1-4, the mutant
shown consistently to be dimerization-deficient in vitro, accumu-
lated in the nucleus to the same level as wild type (WT), indicating
that dimerization of ERK1 is not required for nuclear entry and
retention. Consistent with this finding, energy migration Fo¨rster
resonance energy transfer and fluorescence correlation spectros-
copy measurements in living cells did not detect dimerization of
GFP-ERK1-WT upon activation. In contrast, the kinetics of
nuclear accumulationandphosphorylationofGFP-ERK1-4were
slower than that ofGFP-ERK1-WT.These results indicate that the
differential shuttling behavior of the mutant is a consequence of
delayedphosphorylationofERKbyMEKrather thandimerization.
Our data demonstrate for the first time that a delay in cytoplasmic
activation of ERK is directly translated into a delay in nuclear
translocation.
Stimulation of numerous cell surface receptors leads to acti-
vation of the Raf/MEK7/ERK signaling pathway. In this kinase
cascade, Raf phosphorylates only MEK, and MEK phosphory-
lates only ERK, whereas ERK is able to phosphorylate many
substrates in nearly all cell compartments (1). Noncatalytic
activation of a fewpartners by c-Raf is well documented, but the
biological outcomes of the ERK pathway are predominantly
driven by the kinase activity, as evidenced, for example, by
chemical inhibition (reviewed in Ref. 2). ERK is primarily
located in the cytoplasm of resting cells, although overexpres-
sion results in cytoplasmic and nuclear localization (3). It has
long been recognized that in the course of physiological signal
transduction, ERK accumulates in the nucleus after acute stim-
ulation of the cell (3, 4). Nuclear translocation of ERK is
required for cell cycle entry. Thus, retention of ERK in the cyto-
plasm alters neither ERK kinase activity nor phosphorylation of
cytoplasmic substrates, whereas ERK-dependent transcription
and cell proliferation are blocked (5). It has been demonstrated
that ERK phosphorylates the Phe-Gly nucleoporins Nup50,
Nup153, and Nup154, reducing importin--mediated nucleo-
cytoplasmic transport (6). This observation would expand the
role of ERK nuclear entry to include the regulation of nucleo-
cytoplasmic transport of certain classes of proteins while cross-
ing the nucleopore.
MEK functions as the cytoplasmic anchor for ERK such that
MEK co-overexpressionmaintains the cytoplasmic localization
of overexpressed ERK, whereas saturating levels of the ERK-
binding site ofMEK abrogates ERK export from the nucleus (7).
MEK is sequestered in the cytoplasm as a consequence of active
export out of the nucleus mediated by its nuclear export
sequence. MEK binds to inactive ERK in resting cells (8). The
natural regulation of ERK translocation has also been demon-
strated by differential expression of cytoplasmic anchors such
as PEA15 (9, 10) or Sef (11) or expression of nuclear anchors
such as DUSP5 (12) or Vanishing (13). It has been shown that
the stimulation-induced nuclear accumulation of ERK requires
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the synthesis of short lived nuclear anchors (14). Clearly, regu-
lation of ERK nuclear translocation is an essential feature of the
Raf/MEK/ERK signaling cascade.
The precise mechanism of ERK transport across the nuclear
pore is not fully understood. ERK lacks a nuclear localization
sequence, leading to the suggestion that ERK may enter by a
piggyback mechanism via binding to nuclear localization se-
quence-containing proteins (5). Nuclear localization sequence-
dependent mechanisms require energy for Ran-dependent
cycling of importins (15). However, reconstituted import assays
have shown that ERK can bind directly to FXFG sequences of
nucleoporin in the lumen of the nuclear pore complex, indicat-
ing that it may enter the nucleus in the absence of energy
sources or cytosolic factors (16, 17). Point mutations of ERK
revealed that inactive and active ERK interact with nucleopor-
ins via different domains; thus, both active and inactive ERK
can be transported across the nuclear pore in an energy-inde-
pendent fashion (18). However, it has also been proposed that
active transport of ERK may also occur and that it requires
dimerization of the protein driven by phosphorylation of the
TEY activation loop (19). Indeed, in a reconstituted import
assay, thiophosphorylated ERK2 import increased in the pres-
ence of energy (20). Overall, these observations suggest a role
for both an energy-dependent (presumably via dimerization)
and an energy-independent mechanism (via direct binding to
nucleoporins) in ERK cytoplasmic-nuclear translocation.
Surprisingly, the role of ERKdimerization in nucleocytoplas-
mic shuttling has proven to be controversial. Two distinct
“dimerization mutants” have been used in several studies as
follows: the mutation of histidine 176 to glutamic acid plus
four leucines to alanines (H176E,L333A,L336A,L341A,L344A
orH176EL4Amutant) or the removal of histidine 176 and three
adjacent amino acids (deletion 174–177 or 4 mutant). Ini-
tially, both mutants were shown to not dimerize in vitro and
to not accumulate in the nucleus (19), and later it was demon-
strated that they remained monomeric in vitro at physiological
salt concentrations (21). However, further studies using the
H176E L4A mutant indicated its translocation to be normal
(unless fused to -galactosidase) (22, 23), although others
found another replacementmutant,H176AL4A, to accumulate
even in starved cells (24); this mutant without the glutamic
chargewas not tested in vitro for its capacity to dimerize.More-
over, dimerization could not be detected in live cells through
FRET measurements between co-expressed yellow fluorescent
protein-ERK and cyan fluorescent protein-ERK (23). Recently,
it has been suggested that ERK dimerization plays a role in the
activation of cytoplasmic substrates but not nuclear substrates
(25). In parallel investigations focused on the nature and func-
tional role(s) of ERK interactions with mitochondria, it was
determined that dimerization of human ERK1 was favored in
the mitochondria, also occurred in the nuclei, but was hardly
detectable in the cytosol of HeLa cells (26). In view of these and
other somewhat disparate assessments of ERKdimerization,we
examined in detail the dimerization mutant ERK1-4 because
several studies have reported that the relatedmutation in ERK2
leads to abnormal nuclear translocation (19, 22, 27).
In attempts to retain a normal cytoplasmic localization of
ERK transfected to high levels of expression, several studies
have resorted to co-expression of MEK (22, 23, 27), although
others have imaged cells expressing very low levels of ERK (28).
ERK co-expressed with MEK generally displays an abnormally
short persistence in the nucleus following stimulation, ranging
from10 to 40min (23, 27, 29) instead of several hours in the case
of endogenous ERK. In our studies, we used a mouse embryo
fibroblast ERK1-knock-out cell line (MEFERK1/ (30)). The
lack of endogenous ERK1 allowed us to transfect MEFERK1/
cells with GFP-ERK1 while maintaining theMEK-ERK balance
and ensuring that every ERK1 in the cell is GFP-tagged.
Using this system, we examined ERK1 localization, cytoplas-
mic-nuclear translocation, and dimerization in live cells using
fluorescence microscopy techniques. Our results demonstrate
that themutant displays delayed kinetics of nuclear entry/shut-
tling but no differences in overall nuclear accumulation. These
real timemeasurements in ERK1 knock-out cells help to recon-
cile previous discrepancies between studies with ERK “dimer-
izationmutants,” by emphasizing that the differences inmutant
and WT ERK are subtle, and the ability to resolve these differ-
ences is dependent on the time scale of the measurements. We
also found thatmutation of the dimerizationmotif delayed ERK
phosphorylation, suggesting that the mutant is less efficiently
phosphorylated byMEK.Our study reveals that dimerization of
ERK is not required for nuclear entry but rather that the effi-
cient activation of ERK byMEK is the key determinant of rapid
nuclear translocation.
EXPERIMENTAL PROCEDURES
Gene Construction and Sample Preparation—Full-length
cDNA of human ERK1 subcloned into pcDNA3 vector
(Invitrogen) was subjected to site-directed mutagenesis with
the QuikChange site-directed mutagenesis kit (Stratagene) to
remove the codons for amino acids Pro193–Asp196 and generate
ERK1-4. GFP-ERK1-WT and GFP-ERK1-4 were generated
by PCR cloning of human ERK1 or human ERK1-4 into
PCR2.1 TOPO (Invitrogen) followed by ligation into the XhoI
and BamHI sites of pEGFP-C1 vector from Clontech.
Mouse embryo fibroblast ERK1 knock-out cells (MEFERK1/
(30)) were cultured in DMEM 10% fetal calf serum and were
transfected using Lipofectamine 2000 (Invitrogen) according to
themanufacturer’s protocol. Transient transfections were used
within 48 h. For microscopy, cell monolayers were cultured in
8-well Lab-Tek chamber slides (Nunc, Rochester, NY). Cells
were starved (0 or 0.1% serum) for 4–12 h. Live cell imagingwas
carried out in Tyrode’s buffer with 20 mM glucose and 0.1%
bovine serum albumin, and samples were maintained at
34–36 °C by an objective heater (Bioscience Tools).
For immunofluorescence, transfected cells were plated
on coverslips and fixed with methanol at 20 °C at different
time points after addition of 10% serum. Anti-phosphorylated
ERK1/2 and goat anti-mouse-Cy3 secondary were from Sigma.
Confocal Microscopy—Fluorescence imaging and fluores-
cence recovery after photobleaching (FRAP) were performed
using a Zeiss LSM510 confocal microscope with a 63 1.2 NA
water objective or 63 1.4 NA oil objective. GFP was excited
and bleached using a 488-nm laser line. Photobleaching of a
region of interest was achieved by increasing the laser to 95%
power. To determine the recovery time for the bleach experi-
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ments, images were background-subtracted, and post-bleach
curves were fit to Equation 1,
It  Io  A1  expt/ (Eq. 1)
where Io is an offset; A is the amplitude; t is time, and  is the
characteristic recovery time.
Live cell anisotropy measurements for detection of energy
migration Fo¨rster resonance energy transfer (emFRET or
homo-FRET) were carried out with a Zeiss LSM 510-META
confocal laser scanning microscope incorporating a polariza-
tion beam splitter so as to simultaneously record the parallel (I)
and perpendicular (I) polarized emission signals. GFP was
excited at 488 nm, and emission was collected using 505–
530-nm bandpass filters. Images were acquired using a 63 1.2
NA oil objective with a confocal slice thickness of 1 m. An-
isotropy (r) was calculated from r 	 (I  GI)/(I  2GI),
where G is the correction factor for the difference in the sensi-
tivity of the two detectors. G 	 I/I was determined from a
sample with r	 0 (in our case, fluorescein in aqueous solution).
For more details, see Refs. 31, 32.
Fluorescence Correlation Spectroscopy—Fluorescence cor-
relation spectroscopy (FCS) was performed with an inverted
microscope (Eclipse TE200, Nikon) using the 488-nm line
(narrow pass interference filter, CVI-MellesGriot) of an argon
ion laser (Ion Laser Technology) as the excitation source. The
beam intensity was stabilized with a laser amplitude stabiliza-
tion system (Conoptics). Fluorescence emission was detected
with a photon-counting avalanche photodiode (SPCM-AQR,
PerkinElmer Life Sciences). Digital signal correlation was
performed using a Flex02-03D auto/cross-correlator (Correla-
tor). A 60, 1.4 NA oil immersion objective (Zeiss) was used.
Correlation data at times shorter than that corresponding to
the laser stabilization feedback frequency (
200 kHz) were
discarded.
The beam waist, w0, measured using a variation of the knife-
edge scanmethod (33), was 0.266m.The axial acceptancewas
determined to be 4m, by scanning a thin fluorescent film in z.
FCS correlation curves were fit withMATLAB using the Gaus-
sian acceptance approximation (34) shown in Equation 2,
G 
1
N1  o
11 k2 o
1/ 2
(Eq. 2)
where N is the number of diffusing species in the sample vol-
ume; o is the diffusion time, and k is a fixed parameter that
accounts for the differing axial and lateral dimensions of the
sample volume.
All measurements were performed with a laser irradiance
estimated as 
4 kilowatts/cm2 in the sample plane from mea-
surements with an optical powermeter (model S110, Thorlabs)
and estimations of the image field. Increasing the laser intensity
2-fold had a negligible effect on o, demonstrating that neither
photophysical saturation nor photobleaching biased the mea-
surements (see supplemental Table S1). This result was also
consistent with prior reports of the photobleaching sensitivity
of FCS (35, 36). The low illumination intensity used for FCS
precluded the population of the enhanced GFP triplet state
(37). Brightness (F/N), the average fluorescence intensity (F)
divided by the number of molecules in the observation volume
(N), a quantity determined from the fluorescence fluctuations,
was used to monitor the aggregation state of ERK.
The number of molecules (N) per volume was used to calcu-
late GFP-ERK concentration. Because the axial acceptance of
the FCS measurements was larger than the height of the cells,
we performed electron microscopy measurements of starved
MEFERK1/ cells, leading to estimates of nuclear and cytoplas-
mic thickness, 2.2  0.4 and 1.7  0.6 m, respectively. The
calculations of concentration were corrected accordingly.
Western Blot Phosphorylation Analysis—CCL39 (Chinese
hamster lung cell) fibroblasts were stably transfected with
pcDNA3-GFP-ERK1 or pcDNA3-GFP-ERK1-4. After selec-
tion with 500 g/ml G418 (Invitrogen), cells were grown 3
weeks to stabilize expression at low levels, and GFP-expressing
cells were sorted with a FACS-ARIA (BD Biosciences). Cells
were grown to confluency in DMEM incubated in 5% CO2 at
37 °C and then for 24 h in serum-free DMEM. Three hours
prior to stimulation, cells were incubated at 37 °C in DMEM
lacking sodium bicarbonate (catalogue no. 1280, Invitrogen)
and supplemented with 25 mM Na-Hepes, pH 7.4. Cells were
stimulated with a large volume to reach 10% serum final con-
centration, and were then washed rapidly in ice-cold phos-
phate-buffered saline prior to lysis and boiling in Laemmli sam-
ple buffer. Proteins from lysates were separated by SDS-PAGE
(10% acrylamide/bisacrylamide 29:1 gels), and transferred onto
polyvinylidene difluoride (Immobilon-P fromMillipore). Phos-
phorylated ERK1/2 was detected with the monoclonal anti-
phospho-ERK1/2 antibody M8159 from Sigma. Total ERK was
detected with rabbit serum E1B 1:3000 (38). Secondary anti-
bodies coupled to horseradish peroxidase were purchased from
Promega, and chemiluminescence was used to detect immuno-
reactive bands on autoradiography film to obtain high resolu-
tion images and with the Gnome detector from Syngene
(United Kingdom) to quantify the data.
Antibodies for Immunofluorescence Studies—Monoclonal
anti-phospho-ERK was purchased from Sigma (M8159) and
used at 1:500. Anti-ERK1 antibody R2 was purchased from
Upstate Biotechnology, Inc. (catalogue number 06-182, immu-
nopeptide consisting of the last 35 amino acids of rat ERK1),
diluted 1:1000. Secondary antibodies were AlexaFluor-labeled
anti-mouse or anti-rabbit fromMolecular Probes.
RESULTS
ERK1 Localization—The study of ERK nuclear translocation
has classically required fluorescent tagging of the transfected
molecules and often the co-expression of MEK to avoid sat-
uration of cytoplasmic anchors. Tagging can alter the mecha-
nism of translocation, and in addition, the co-expression of
MEK has often led to a shorter than expected duration of ERK
nuclear localization (23, 27, 29). Therefore, we initially charac-
terized ERK1 nuclear translocation using untagged ERK1 in
MEFERK1/ cells devoid of endogenous ERK1, presuming that
the endogenousMEKwas available to allownormal localization
of transfected ERK. Furthermore, we compared translocation
of ERK1-WT with that of the dimerization mutant ERK1-4.
The supplemental Fig. S1 demonstrates that anti-ERK1 anti-
body (R2) bound efficiently to ERK1 in wild type MEF cells,
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whereas no signals were obtained in MEFERK1/. This is the
first demonstration of an ERK1-specific antibody that can be
used to study ERK1 subcellular localization without cross-
labeling of ERK2. Furthermore, ERK1 transfected into
MEFERK1/ cells was detected readily with our anti-ERK1 R2
antibody (supplemental Fig. S2), and the time course of nuclear
translocation closely mimicked that of endogenous ERK1 in
WTMEF cells (data not shown). Indeed, transfected ERK1-WT
could be detected in the nucleus within 5min after stimulation,
and nuclear accumulation persisted for several hours, still being
maximal after 2 h of stimulation (supplemental Fig. S2). Sur-
prisingly, ERK1-4 behaved similarly to ERK1-WT. As shown
in supplemental Fig. S2, at 10 min the ERK1-4 was already
localized in the nucleus, where it was present for at least 2 h, as
in the case of ERK1-WT. To probe for differences betweenWT
and mutant, we blocked protein synthesis prior to stimulation
to impede synthesis of nuclear anchors. In the presence of
cycloheximide, both ERK1-WT and ERK1-4 failed to accu-
mulate in the nucleus by 2 h post-stimulation (supplemental
Fig. S3). These results demonstrate that in cells lacking endog-
enous ERK1, both ERK1-WT and ERK1-4 behave like endog-
enous ERK1. The “snapshot” immunofluorescence studies did
not reveal differences between the behavior of ERK1-WT
and ERK1-4. Considering that the differences may have been
subtle, and therefore requiring finer temporal resolution, we
resorted to GFP fusion proteins of ERK1 for real time micros-
copy studies.
To verify that adding the 27-kDa GFP to the 44-kDa ERK
does not affect the properties of ERK1, we performed control
experiments indicating that GFP-ERK1-WT mimicked the
nucleocytoplasmic localization patterns of endogenous ERK.
Fig. 1, upper row, shows that GFP-ERK1-WT localized to the
cytosol in resting cells. As expected, serum addition triggered
rapid nuclear translocation within 13min, andGFP-ERK1-WT
was retained in the nucleus for 2 h post-stimulation. This result
was in agreement with those gained in experiments tracking
endogenous ERK1 in wild type MEF cells and untagged ERK1
transfected inMEFERK1/ (supplemental Fig. S2). At 3 h post-
stimulation, GFP-ERK1-WT nuclear accumulation was mark-
edly diminished (Fig. 1).
We also evaluated the activation of total ERK by following
the kinetics of dual phosphorylation by MEK (Fig. 1, 2nd
row). Cells were starved for 12 h to avoid decreasing expres-
sion of transfected ERK; in these cells, the level of phosphory-
lated ERK was low in both transfected and untransfected cells
(Fig. 1, 0 min, 2nd row). Hence, both endogenous ERK2 and
GFP-ERK1-WT were maintained inactive in the cytoplasm in
the starved cells. Upon stimulation, phosphorylated ERK
increased markedly in all cells and accumulated rapidly in the
nucleus (Fig. 1, 13 min, 2nd row). The higher signal in trans-
fected cells at 13 and 60min reveals that both the short and long
term nuclear accumulation of phosphorylated GFP-ERK1-WT
closely paralleled the localization of endogenous phospho-
ERK2 in the nontransfected MEFERK1/ cells. As reported
previously (14), GFP-ERK1-WTwas sequestered in the nucleus
even after dephosphorylation had occurred (Fig. 1, 120 and 180
min, 1st row), as evidenced by the persistent nuclear GFP signal
and loss of phospho-ERK (120 and 180 min, 2nd row). Collec-
tively, these results indicate that the presence of theGFP tag did
not alter either the subcellular localization or the activation
patterns of ERK1.
FIGURE 1. Localization of GFP-ERK1 inMEFERK1/ cells.MEFERK1/ cells expressing GFP-ERK1 (top row, green in overlay) and endogenous ERK2were fixed
inmethanol at20 °C after starvation for 12 h (time 0) and at different time points after activation by addition of serum. Cells were stained for phosphorylated
ERK1/2 (middle row, red in overlay).
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Live Cell Studies of ERK1 Nuclear Accumulation—We stud-
ied the real time dynamics of GFP-ERK1 in living cells. Cells
overexpressing GFP-ERK1 to a high degree showed the ex-
pected accumulation of GFP-ERK1 in the nucleus even in the
starved state (as reported previously (3, 8, 28)). However, cells
expressing at a physiologically relevant level demonstrated
the characteristic retention of GFP-ERK1 in the cytoplasm of
unstimulated cells (Fig. 2A and supplemental movie S1).
Because the transient transfection resulted in a range of expres-
sion levels, we visually selected cells using the criterion that the
nucleus be no brighter than the cytoplasm in the starved state.
We verified that the expression level of GFP-ERK1 was physio-
logically relevant by using FCS to determine the upper limit of
concentration considered, i.e.when the nucleus and cytoplasm
displayed equal intensity in the resting condition. In this case,
the GFP-ERK1 concentration was 0.82  0.4 M in the cyto-
plasm and 0.77  0.2 M in the nucleus, values still within
endogenous expression levels (39).
Upon addition of 10% serum, GFP-ERK1 accumulated rap-
idly in the nucleus (Fig. 2B, supplemental movie 1). Real time
measurements of GFP-ERK1 nuclear translocation allowed the
quantification of two characteristic parameters (Fig. 2C) as fol-
lows: the stimulated steady-state nuclear concentration of
GFP-ERK1 relative to the resting concentration (A), and the
time after stimulation atwhich the concentration had increased
to half of the maximum (t1⁄2 or “half-time”). These real time
measurements revealed that in response to activation, mutant
ERK1 accumulated in the nucleus to the same extent as theWT
protein (Fig. 3A). However, the t1⁄2 for nuclear accumulation of
GFP-ERK-4 was nearly double that ofWT (Fig. 3B). Free GFP
was shown to distribute in both the cytoplasm and nucleus, and
its subcellular localization did not change upon stimulation
(data not shown). The lack of a response of free GFP to stimu-
lation verified that the observed GFP-ERK results were physio-
logically relevant and that the slower rate of themutant to reach
steady statewas specific to ERK function.Nuclear translocation
of GFP-ERK1 mimicked endogenous ERK also because lepto-
mycin B (LMB) treatment of resting cells induced the expected
nuclear accumulation of GFP-ERK1, although accumulation
was to a lower level than when cells were serum-stimulated
(data not shown). LMB induces nuclear accumulation in the
absence of stimulation by inhibiting the nuclear export protein
CRM1 and thereby reducing active nuclear export ofMEKERK
complexes (8).
To determine whether the rate of shuttling of ERK into the
nucleus changes with activation, we used a FRAP protocol that
bleached the entire nucleus and monitored the recovery of the
nuclear GFP intensity as a result of equilibration by exchange
between unbleached cytoplasmic and photobleached nuclear
GFP-ERK1 (Fig. 4). Both theWT and mutant ERK were slower
to recover than free GFP after photobleaching the nucleus in
FIGURE 2.Kinetics of GFP-human ERK1 nuclear accumulation. A, before (0
s) stimulation (cell starved for 12 h), GFP-ERK1-WT (gray) is retained in the
cytoplasm and shows the characteristic dark nucleus. B, after stimulation (at
339 s), GFP-ERK1-WT accumulates in the nucleus. C, GFP intensity in the
nucleus normalized to initial value as a function of time after serum stimula-
tion. The curves were fit to a sigmoidal function (solid gray line) to extract the
half-time to saturation (t1⁄2) and the steady-state saturation level (A).
FIGURE 3. Characterization of nuclear ERK1 accumulation. Comparison of
accumulation levels (A) and t1⁄2 (B) for GFP-ERK1-WT and GFP-ERK1-4.
Nuclear accumulation was induced by addition of 10% serum.
ERK Nuclear Translocation Is Independent of Dimerization
3096 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 5•JANUARY 29, 2010
 at UKB - Universiteit Twente Centrale Bibliotheek, on June 7, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
resting cells. This result could reflect sterically hindered diffu-
sion of ERK across the nucleopore or ERK retention in the
cytosol by binding protein complexes, or a combination of both
processes. During stimulation, the free GFP recovery time was
unchanged; however, the GFP-ERK1-WT recovery time was
faster than resting, consistent with observations by Costa et al.
(28). Similarly, Ando et al. (40) have demonstrated that cell
stimulation enhances the rates of ERK nuclear import and
export. Whereas GFP-ERK1-4 also displayed an increase in
shuttling time during stimulation, it was still slower than for the
WTprotein (higher  value). The slower exchange kineticswere
consistent with the slower nuclear accumulation of the mutant
upon stimulation of resting cells.
ERK1 Diffusion Is Not Changed by Activation—Using FCS,
we determined diffusion coefficients of the ERK constructs in
both the cytoplasm and the nucleus, before and after activation.
No evidence for systematic changes in diffusion was seen after
stimulation, and no significant differences between WT and
mutant were detected (Table 1). This result indicates that the
acceleration of the nucleocytoplasmic rate of shuttling upon
stimulation was not a result of increased mobility in a given
compartment. Mobile (free) GFP-ERK1 diffused at a rate one-
third that of free GFP. From hydrodynamic considerations,
GFP-ERK should have a diffusion constants 60–70% that of free
GFP, on the basis of their molecularmasses and assuming ellip-
soidal molecules with axial ratios not exceeding
4 (41). Thus,
the slower diffusion of GFP-ERK likely reflects interactions
with nuclear and cytoplasmic partner proteins.
Sequestration of ERK in the nucleus has been reported (13,
14), leading to the suggestion that one ormore “nuclear anchor”
proteins retain ERK in the nucleus. The diffusion coefficient in
the nucleus after stimulation did not diminish (Table 1). How-
ever, immobile proteins do not contribute to the fluctuation
signal and thus do not influence the determination of diffusion
constants by FCS. To determine whether ERK1 can bind to
anchors that immobilize it in the nucleus, we used a FRAP pro-
tocol that involved photobleaching the entire cytoplasm and
half of the nucleus, thus allowing a determination of intranu-
clear GFP-ERK1 redistribution (supplemental movie 2). Fig. 5A
shows a typical result from such a photobleaching series. From
these experiments, it is clear that ERK1 was not immobilized in
the nucleus but rather diffused freely and re-equilibratedwithin
the nucleus in seconds. Bothwild type andmutant ERK1 exhib-
ited this property in the resting and activated states, with no
reduction in mobility after stimulation (Fig. 5B). Control FRAP
experiments showed that free GFP is more mobile than GFP-
ERK1 (in qualitative agreement with FCS), as expected because
it is smaller and does not interact with binding partners. We
conclude that ERK1 either binds only transiently to nuclear
targets or that the complexes formed by ERK and nuclear tar-
gets are inherently highly mobile.
ERK1Dimerization Is Not Detected in Living Cells—Based on
the ability of GFP-ERK1-4 to accumulate in the nucleus, we
hypothesized that dimerization is not required for nuclear
translocation. Despite the evidence for dimerization from in
vitromeasurements (19, 21), others have failed to detect dimer-
ization via FRETmeasurements between cyan fluorescent pro-
tein-ERK and yellow fluorescent protein-ERK (23) in living
cells. We performed further experiments using emFRET and
FCS to confirm that homodimerization was not occurring.
MEFERK1/ cells transfected with GFP-ERK1 were ideal for
these studies because all the ERK1 is GFP-tagged, such that
even a small percentage of ERK dimers should have been
detectable.
FCS experiments were performed with both GFP-ERK1-WT
andGFP-ERK1-4. To search for evidence of dimerization, the
number of independent mobile objects (N) in the focal volume
was determined by FCS, and the normalized fluorescence
intensity (F/N) was calculated. Dimerization of ERK would
cause an increase in F/N, because the number of diffusing
objects would be reduced upon dimerization, whereas the total
fluorescence intensity would remain the same. This method
was validated using fluorescein-labeled DNA and comparing
F/N values for single-stranded and double-stranded DNA. The
control experiments yielded the expected ratio of 2 (2.05 
0.06) for double/single-labeled molecules (see “Experimental
Procedures” and supplemental Table S2). In live cells, no
change in the dimerization state (invariant F/N values) of GFP-
FIGURE 4. FRAP measurements with photobleaching of the entire nu-
cleus tomeasurenuclear exchange.ComparisonofGFP recovery after pho-
tobleaching the nucleus for free GFP, GFP-ERK1-WT, and GFP-ERK1-4. In
both starved and stimulated state, WT recovery is faster than mutant.
TABLE 1
Results from FCSmeasurements
Values are given as average S.E. “Starved” indicates measurements before serum
addition, and “serum” data were acquired in the cytoplasm from 1 to 10 min after
serum addition and in the nucleus from 10 to 15 min. F/N is fluorescence intensity
per mobile object (see under “Experimental Procedures”).
F/N D N
counts/object/s m2/s
GFP cytoplasm 319 10 17.5 1.3 7
GFP nucleus 308 8 16.1 0.7 18
WT cytoplasm starved 316 8 7.7 0.4 31
WT cytoplasmserum 308 5 6.6 0.3 49
WT nucleus starved 283 14 7.1 0.8 13
WT nucleusserum 299 11 6.8 0.6 19
4 cytoplasm starved 346 8 6.4 0.4 16
4 cytoplasmserum 309 9 6.7 0.4 9
4 nucleus starved 296 13 5.2 0.4 17
4 nucleusserum 278 10 5.7 0.4 20
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ERK1 was detected after stimulation with serum (Fig. 6). GFP-
ERK1-WT (Fig. 6A) and GFP-ERK1-4 (Fig. 6B) showed the
same behavior. In addition, the F/N values for the ERK con-
structs did not differ significantly from the value for freemono-
meric GFP expressed in MEFERK1/ cells (Table 1).
In agreement with the FCS determinations, emFRET mea-
surements also failed to detect dimerization of GFP-ERK1 in
thecell cytoplasmuponstimulation. emFRETbetween like fluo-
rophores does not result in changes in the ensemble fluores-
cence intensity or lifetime. However, it leads to depolarization
of the emission because of the lack of correlation between the
orientation of the secondarily excitedmolecule (the “acceptor”)
and that of the initially photoselected “donor” (32, 42). Thus,
the formation of proteinprotein complexes that bring individ-
ual GFPswithin the emFRET range (8 nm) can be determined
by measurement of the steady-state anisotropy. Note that the
rotation of the protein plays essentially no role in depolariza-
tion, as the rotational time scale (for any GFP fusion protein) is
much longer than the fluorescence lifetime. Thus, binding of
the target protein to unlabeled partners will not alter the
emFRET signal.
Fig. 6C features anisotropy measurements in a live MEFERK1/
cell expressing GFP-ERK1-WT. After stimulation with serum,
FIGURE 5. ERK1 redistributed rapidly in the nucleus. A, sample trace from
photobleaching protocol that photobleached the entire cytoplasm and half
the nucleus. GFP-ERK1-WT from the unbleached region (black) quickly redis-
tributed throughout the nucleus, filling in the bleached region (red). B, redis-
tribution times before (in starved cells, t 	 0) and after activation with 10%
serum. Activated GFP-ERK1-WT (black squares) had a similar redistribution
time to nonactivated ERK1 that accumulated in the nucleus due to LMB treat-
ment (red circles at t	 0). No significant change in the ability of GFP-ERK1 to
redistribute was observed after serum stimulation. Note that GFP redistribu-
tion was so rapid that measurements had to be taken at room temperature,
and all GFP-ERK1measurementswere at 30 °C.Measurements of GFP-ERK1 at
35 °C exhibited similar redistribution times (data not shown). Each point rep-
resents a measurement from a single cell.
FIGURE 6.Dimerizationwasnot detectedby FCSor emFRET. FCSwas used
to calculate the fluorescence intensity per mobile object (F/N). No significant
change in F/Nwasobservedafter stimulation for eitherWT (A) ormutant ERK1
(B), indicating that ERK1 remained monomeric after activation. Each symbol
after activation indicates a single measurement. Connected symbols are
measurements from the same cell over time. Values are normalized to the F/N
value before stimulation and absolute values are found in Table 1. The gray
band represents the single cell standard deviation of prestimulation (t 	 0)
measurements. C, emFRET measurements in a live cell expressing GFP-
ERK1-WT during activation. After serum stimulation, GFP-ERK-WT accumu-
lates in the nucleus (blue line); however, the anisotropy values in both the
cytoplasm (black) and nucleus (red) remained unchanged.
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the intensity in the nucleus (Fig. 6C, blue line) increased as
GFP-ERK1-WT translocated, yet no change in anisotropy (red
and black lines) was detected. We conclude that ERK1 re-
mained monomeric. Anisotropy measurements of unstimu-
lated GFP-ERK1-WT sequestered in the nucleus after LMB
treatment or serum-stimulated GFP-ERK1-4 produced simi-
lar results (data not shown). The absence of ERK1 homodimer-
ization is consistent with previous ERK2 hetero-FRET mea-
surements (23).
Phosphorylation Kinetics Are Different for Wild Type and
Mutant ERK—The inability to detect ERK1 homodimers estab-
lished that dimerization could not account for the observed
differences in nuclear accumulation kinetics between the WT
and 4 mutant (Fig. 3B). Because the mutant accumulated to
the same extent as ERK1-WT (Fig. 3A), we could also rule out
gross structural modification as the mechanism. Furthermore,
even though the mutant was consistently slower than WT at
entering the nucleus, its nuclear entrywas still accelerated upon
stimulation (Fig. 4). We therefore examined more closely the
kinetics of activation of the two proteins, measured by their
double phosphorylation by MEK on the TEY sequence. Only a
minor proportion of transiently transfected MEF cells ex-
pressed GFP-ERKs, and thus the kinetics were compared in
stably transfected CCL39 fibroblasts. After selection, cells were
cultivated in exponential conditions for about 3 weeks to gen-
erate a moderate, stable level of expression and then sorted by
fluorescence-activated cell sorter. More than 1000 clones ini-
tially resistant to geneticin were combined, thereby averaging
out possible differences between individual clonal lines. Starved
cells were stimulated for a time course encompassing that of
nuclear entry of ERK and phosphorylation quantified byWest-
ern blotting. Fig. 7A shows the kinetics of ERK phosphorylation
in cells stably transfected with either GFP-ERK1-WT or GFP-
ERK1-4. The endogenous ERK in each cell population dis-
played nearly identical kinetics of ERK phosphorylation, con-
firming that the samples had been treated equally, and the
differences between WT and 4 were physiologically relevant
(Fig. 7A). GFP-ERK1-WT showed a nearly 2-fold faster phos-
phorylation kinetics (half-time 1.8  0.03 min) than GFP-
ERK1-4 (3.0  0.02 min). Three independent experiments
indicated reproducibly that the GFP-ERK1-4 was activated
more slowly than GFP-ERK1-WT. The nearly 2-fold delay in
phosphorylation correlated well with the nearly equally
retarded nuclear accumulation of GFP-ERK1-4.
In principle, a slower phosphorylation of mutant ERK
could be caused by slower MEK activation or perhaps by a
general defect of the mutant in its interactions with partners.
Because MEK and phosphatases bind to ERK via the same
docking site (43), we determined the kinetics of ERK dephos-
phorylation after chemical inhibition of MEK. Endogenous
ERK, GFP-ERK1-WT, and GFP-ERK1-4 dephosphorylated
within 3 min and at similar rates after blocking MEK activa-
tion with PD184359 (Fig. 7B). The same result was obtained
when the cells were stimulated 2 h prior to addition of the
MEK inhibitor (data not shown).We conclude that ERK1-4
was dephosphorylated by endogenous phosphatases as effi-
ciently as the wild type protein, implying that the observed
differences in nuclear accumulation kinetics between wild
type and 4 were likely caused by slower MEK phosphoryla-
tion, rather than by global changes in the interactions with
partners.
DISCUSSION
The outcomes of signaling via the mitogen-activated protein
kinase pathway are determined by the regulation of ERK
nuclear translocation (5, 10, 44), which is required for activa-
tion of many transcription factors. The duration and extent of
translocation is dependent on the type of stimulus, and ERK
nuclear translocation is required to induce specific responses in
the form of gene expression (45). In some cases stimulus-de-
pendent regulation of nuclear translocation may be linked to
distinct elevation of calcium concentration triggered by ago-
nists (46). Proteins that regulate ERK nuclear translocation
have been identified, including PEA15, which anchors ERK in
the cytosol (9) in part by inhibiting the capacity of ERK to bind
to nucleoporins (47), and Sef, which blocks the dissociation of
MEKERK complexes (11).
FIGURE 7. Phosphorylation kinetics were different for ERK1-WT and
ERK1-4. A, plot of phosphorylation over time. Solid lines (cells transfected
with mutant ERK) and hatched lines (cells transfected with wild type ERK) are
sigmoidal fits to the data to determine the t1⁄2 values 95%confidence inter-
val (see text). Each trace was normalized to the fit maximum. B, relative phos-
phorylation levels of ERK1 in cells stimulated for 15min and then treatedwith
PD184359, blocking MEK activation and allowing the dephosphorylation of
ERK.
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Because of the rapid nature of ERK nuclear translocation, we
fluorescently tagged ERK to study its shuttling dynamics in liv-
ing cells by quantitative microscopy. To ensure that expression
of GFP-ERK1 did not overwhelm the system, we expressed
GFP-ERK1 in MEKERK1/ cells, thus avoiding saturation of
ERK1/2 partners. The average concentration of GFP-ERK1 in
our experiments was on the order of 1 M, a value similar to
the endogenous levels of total ERK reported recently by
Fujioka et al. (39) for HeLa and Cos cells (0.96 and 0.81 M,
respectively.) These authors reviewed the results of other stud-
ies, two reporting low concentrations (0.26 and 0.36 M) and
four concentrations ranging from 1 to 2.1 M. In further con-
firmation of the physiological relevance of our system, we
observed rapid nuclear translocation of GFP-ERK1withinmin-
utes of serum addition. As shown previously for endogenous
ERK (14), nuclear localization of GFP-ERK1 lasted for several
hours, and it was retained in the nucleus after dephosphoryla-
tion. This observation confirms that inactive and active ERK
can be sequestered in the nucleus, presumably via binding to
nuclear anchoring proteins (14).
Nuclear anchoring, however, is not accompanied by
immobilization. GFP-ERK1 was found to be highly mobile,
and its mobility did not depend on activation state, indicating
that ERK binding partners are also mobile or that interactions
are transient. FCS measurements of diffusion constants (Table
1) and FRAP studies showed that GFP-ERK1 redistributed
within seconds throughout the nucleus (Fig. 5). The protein
mobility was similar for unstimulated and stimulated cells (15
min to 2 h post-stimulation). Free GFP diffusion (Table 1) and
nuclear redistribution (Fig. 5) were much faster than for GFP-
ERK1, presumably reflecting the smaller size and lack of bind-
ing partners. The FCS and emFRET measurements did not
detect changes in the aggregation state of ERK1 upon activation
in either compartment (Fig. 6 and Table 1), indicating that ERK
does not homodimerize before or during nuclear translocation.
By blocking CRM1-dependent nuclear export, accumulation
of unstimulated ERK was observed (see Refs. 7, 14 and our data
not shown), indicating that the localization of ERK and ERK
complexes is actively regulated. Constant shuttling of ERK was
further demonstrated by FRAP experiments in resting cells, in
which the nuclear pool of GFP-ERK1 recovered after photo-
bleaching the entire nucleus (Fig. 4). Stimulation of the cells led
to an increase in nuclear recovery of GFP-ERK1, consistent
with previous observations (28) and in support of previous
models in which ERK is released from a cytoplasmic anchor
upon activation, allowing rapid nuclear accumulation (22).
Together with data demonstrating that ERK nuclear entry does
not require energy (16, 17), our results suggest that upon release
from cytoplasmic anchoring after activation, ERK diffuses to
the nucleus while being highly mobile in both compartments at
all times.
To gain more insight into the mechanism of ERK nuclear
translocation, we examined the behavior of the only ERK
mutant shown to display consistently altered nuclear translo-
cation, ERK1-4. To our surprise, ERK1-4 accumulated in the
nucleus to the same level as ERK1-WT. This result was
observedwhennontaggedERK1-4was expressed in cells lack-
ing endogenous ERK1, and it became obvious following statis-
tical measurements of time-lapse studies of GFP-ERK1-4
serum-induced nuclear translocation. In unstimulated cells,
ERK1-4 diffusion in both compartments was similar to that of
WT, consistent with the observation that the unphosphoryla-
ted form of the other dimerization mutant, ERK2-H176E L4A,
translocated normally across the nucleopore in reconstituted
assays comparing active and inactive transport (18). FRAP of
the nucleus also revealed that GFP-ERK1-4 shuttling was
accelerated after stimulation but was not as rapid as GFP-
ERK1-WT. Abnormal folding could not explain this phenome-
non because the kinase activity of ERK2-4 has been found to
be in the range of ERK2 (21).
The dynamics and extent of nuclear accumulation of ERK
may reflect import or export rates or both. Indeed, nuclear
accumulation can be driven by changes in export alone as dem-
onstrated by treatment of resting cells with LMB. The observa-
tion that ERK-4 eventually accumulates to the same extent as
ERK-WT implies that, at steady state, the ratio of import to
export rates is unaffected by the mutation, provided the mech-
anisms of import and export are unchanged. The slower accu-
mulation of the mutant could arise from slowed kinetics
(import and export) or reflect a delay in the conversion of ERK
to an “import-eligible” form, i.e. a delayed phosphorylation.
Nuclear exchange measurements indicate a contribution from
the former, whereas the sigmoidal shape of the accumulation
curves strongly implies the existence of an activation delay as
well.
The fact that the mobilities of WT and mutant ERK1 were
similar in the resting state, despite a delay in nuclear accumu-
lation subsequent to stimulation, led us to hypothesize that the
defect in mutant behavior should be upstream of translocation.
In accordance with this supposition, we found that ERK1-4
was phosphorylatedmore slowly than ERK1-WTand evaluated
by double phosphorylation on theTEYactivating loop (Fig. 7A).
This delay was missed in previous experiments that suggested
normal activation of the ERK2 mutant (H176A L4A) in an end
point immunoblot assay (5min of 12-O-tetradecanoylphorbol-
13-acetate treatment) (24). The difference between ERK1-4
and ERK1-WT was specific to activation because upon chemi-
cal inhibition of MEK, ERK1-4 was dephosphorylated as rap-
idly as WT (Fig. 7B). This normal dephosphorylation is consis-
tent with the observation that the ERK2 mutant H176A L4A
bound normally to the phosphatase MKP3-CS (determined via
immunolocalization studies) (24). Abnormal activation is also
consistent with failure of ERK2-H176A L4A to co-immunopre-
cipitate normally with MEK1 (24). Our data suggest a close
correlation between activation of ERK and the rate of nuclear
accumulation. We conclude that the activation (double phos-
phorylation) of ERK constitutes the trigger of rapid nuclear
translocation.
It has been demonstrated that at the onset of stimulation
ERK is released fromMEK (8) and one can expect that a delay
in activation leads to a delayed release of ERK. This delayed
release would then lead to slower nuclear accumulation
because MEK and inactive ERK complexes are retained in the
cytosol via the nuclear export sequence of MEK (48).We inter-
pret the delay of shuttling during stimulation as a consequence
of the slower re-activation of inactive ERK in complexes with
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MEK. Indeed, the turnover of ERK activation is very fast, as
demonstrated by the total extinction of phospho-ERK within 3
min after blocking MEK activation (Fig. 7B). Furthermore, it
has been demonstrated that at peak stimulation only 5% of
MEKmolecules are active, whereas up to 60%of ERKmolecules
are active (39). Hence, rapidly inactivated ERK molecules are
trapped instantly by the large pool of inactive MEK inside the
cytoplasm, and inefficient activation of ERK1-4 would then
retard further release fromMEK. Our data demonstrate for the
first time that a delay in cytoplasmic activation of ERK is imme-
diately translated into a delay of nuclear translocation, high-
lighting that the constant shuttling of ERK is linked to a rapid
turnover of activation. This constant exchange of ERK, regu-
lated by interactions with binding partners, allows nuclear ERK
responses to act as immediate sensors of signal strength.
Recently, wild type ERK has been shown to migrate as an

80-kDa complex, whereas the ERK dimermutant H176E L4A
did not form an 80-kDa complex or co-precipitate with MEK
(25, 49). Surprisingly, the mutant also prevented endogenous
ERK from forming the complex. These results were interpreted
as demonstrating the formation of homodimers. It is important
to note that the presence of cytoplasmic extracts was required
to form the 80-kDa complex and that it was observed only after
addition of the reducing agent -mercaptoethanol to reduce
highermolecular weight complexes (49). Therefore, although it
is clear that the dimerization mutant is impeded in its ability to
form high molecular weight complexes, it is unclear whether
the 80-kDa complexes represent ERK homodimers. Indeed,
prior to our present work, the existence of ERK dimers in vivo
was already questioned due to the lack of hetero-FRET between
ERKs fused to different fluorescent proteins (23). Interestingly,
dimerization in vitro was demonstrated to occur best at an
osmolarity higher than that of living cells, likely because of the
hydrophobic nature of the interface (21).We have not detected
any differences in aggregation state between ERK1-WT and
ERK1-4, using both FCS and emFRET measurements in live
cells. Our experimental conditions were optimal because all
ERK1molecules expressed were tagged with GFP, and the con-
centration of GFP-ERKs was in the recently determined range
of endogenous ERK expression (39). Our results demonstrate
that ERK1-4 activation is less efficient than that of WT ERK,
possibly due to abnormal formation of the scaffold complex (24,
25). The ability of low levels of ERK dimerization mutants to
displace endogenous ERK from scaffolding proteins such as
KSR1 (25)may indicate a greater affinity of themutants leading
to a decrease in the efficiency of activation by MEK.
It was reported recently that phosphorylation of the SPS
motif of the kinase insert of ERK is necessary for ERK nuclear
translocation (50). Phosphorylation of this SPS motif was
shown to be uncoupled from the activating phosphorylation of
the TEY motif, precluding an involvement of the SPS in the
phenomenon described in this study. However, both mutants
share problems with activation as follows: mutation of SPS
reduces ERK activation markedly, whereas the 4 mutation
delays ERK activation. Furthermore, SPS phosphorylation was
shown to accelerate movement across the nucleopore (50),
whereas ERK dimerization mutants translocate across the
nucleopore normally (18).
Our study demonstrates that although ERK is localized to
cellular compartments, it is not immobilized.We conclude that
the localization of ERK is dictated by the abundance of and
affinity for anchoring proteins to which ERK binds. Further-
more, although ERK constantly shuttles between the cytoplasm
and nucleus, nuclear exchange increases upon activation. The
efficient activation of ERK leads to its release from cytoplasmic
anchoring proteins and to rapid nuclear accumulation. Such a
regulation of MEK-ERK coupling controlling signal transmis-
sion to the nucleus would potentiate a function of nuclear ERK
activity in the discrimination of external signal strength.
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